The $360 Billion Market that Medicine Got Wrong for 20 Years

Summary

The video explores the $360 billion menopause market, long overlooked by pharma, employers, and investors despite affecting half the population. It highlights how celebrity-backed startups, telehealth companies, and FDA regulatory changes are now turning menopause into a fast-growing consumer and healthcare category, though confusion remains over which products actually work.

• Menopause affects half the world's population and causes over $150 billion in annual global productivity losses.
• The U.S. menopause market is estimated at $360 billion, with 75 million American women currently going through it, far exceeding the IVF market.
• Former FDA Commissioner Marty Makary reversed decades-old black box warnings on hormone replacement therapy, calling the prior dogma 'one of the greatest mistakes of modern medicine.'
• HRT prescriptions for women 45+ have more than tripled in the past 5 years and prescribing rates rose over 19% after the FDA label change.
• Startups like Stripes (founded by Naomi Watts) and Midi Health (a telehealth unicorn) are building brands and care platforms around menopause and perimenopause.
• Less than 1% of total healthcare funding goes to women's health, highlighting a massive investment gap.
• As the market grows, women face the challenge of separating evidence-based treatments from unproven wellness products and marketing hype.